Arbutus Biopharma (ABUS) Operating Leases (2019 - 2025)
Arbutus Biopharma's Operating Leases came in at $199,000 for Q4 2025, down 75.3% from $806,000 a year earlier and down 49.1% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Operating Leases (2019 - 2025) Analysis & Trends
Going back to Q1 2019, Arbutus Biopharma's Operating Leases data covers 28 quarters.
- Operating Leases has declined in each of the last six years, with a five-year compound annual growth rate of -40.2% (FY2020 to FY2025).
- Going back by year, Operating Leases was $806,000 in FY2024 (-40.0%), $1.34 million in FY2023 (-26.0%), $1.82 million in FY2022 (-18.6%) and $2.23 million in FY2021 (-14.0%).
- The Q4 2025 figure represents the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year-over-year, Operating Leases has declined for 24 consecutive quarters, with an average decline of 45.8% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 13.7% (Q2 2021) to 75.3% (Q4 2025).
- Business Quant data shows ABUS's Operating Leases at $391,000 (Q3 2025), $575,000 (Q2 2025) and $626,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 199,000.00 |
| Sep 30, 2025 | 391,000.00 |
| Jun 30, 2025 | 575,000.00 |
| Mar 31, 2025 | 626,000.00 |
| Dec 31, 2024 | 806,000.00 |
| Sep 30, 2024 | 978,000.00 |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 1.96 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.23 Mn |
| Sep 30, 2021 | 2.36 Mn |
| Jun 30, 2021 | 2.48 Mn |
| Mar 31, 2021 | 2.48 Mn |
API Access
Arbutus Biopharma Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();